Clin2
NCT06096714Possibly a fitRecruiting

Testing nicotine's addictive threshold in smokers

Smoking Addiction

Treatments studied

Part of Mental health clinical trials.

This study tests how nicotine affects the brain's reward system in people who smoke. It aims to find the level of nicotine that becomes addictive, helping guide future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
45 people
Ages
21 years to 59 years
Study type
Interventional

Who can take part

  • You are between 21 and 59 years old.
  • You have smoked at least once a week for more than one year.
  • You are in generally good health (no major medical or psychiatric conditions).
  • You are not currently trying to quit smoking or receiving treatment for tobacco dependence.
  • If you are a woman, you must use an acceptable method of birth control and not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07771725Not yet recruiting· Phase 1
Sweeteners and nicotine addiction

This study tests how different sweeteners might affect the addictive properties of nicotine. It may help find ways to reduce nicotine dependence.

West Haven, Connecticut
NCT05947162Not yet recruiting
Testing orexin effects to reduce nicotine addiction

This study looks at how a brain system called orexin may affect nicotine addiction. If you smoke regularly and meet diagnostic criteria, the trial may help researchers understand what brain changes could improve nicotine dependence.

Shenzhen, Guangdong
NCT06619964Enrolling by invitation
Study on nicotine levels in e-liquids

This trial tests how different nicotine levels in e-liquids affect people who use pod or pen-style vapes daily. It aims to help regulators make better rules about nicotine content.

Rochester, New York
NCT06582888Recruiting· Early Phase 1
VR attention test for smoking cravings

This study tests whether a virtual reality (VR) program can measure how your brain pays attention to smoking cues. It also involves taking a medication called varenicline (Chantix) to see if it reduces cravings. You may be eligible if you are a daily smoker, have been smoking for at least 3 years, and are not ready to quit in the next month.

San Diego, California
NCT07165808Recruiting
Nicotine pouch abuse liability study

This study looks at how different nicotine pouch products affect people's desire to use them. It may help if you currently use nicotine pouches and are not planning to quit.

Atlanta, Georgia
NCT05665465Recruiting· Early Phase 1
Study how childhood stress may affect future smoking risk

This early study looks at how experiences from childhood may affect brain and behavior patterns related to nicotine and smoking risk. It may help researchers design better prevention strategies for people who have never smoked.

Durham, North Carolina

Hear when a new Smoking Addiction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.